BioCentury
ARTICLE | Company News

MDS, Molecular Insight deal

June 21, 2004 7:00 AM UTC

MDS division MDS Nordion Inc. (Ottawa, Ontario) will manufacture Molecular's BMIPP, which is a molecular imaging product in Phase IIb testing to detect cardiac ischemia in the emergency room. BMIPP is...